These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30074840)

  • 1. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
    Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts.
    Gross GJ; Hsu A; Pfeiffer AW; Nithipatikom K
    J Mol Cell Cardiol; 2013 Jun; 59():20-9. PubMed ID: 23419451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts.
    Gross GJ; Baker JE; Hsu A; Wu HE; Falck JR; Nithipatikom K
    Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2201-7. PubMed ID: 20400686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
    Gross GJ; Gauthier KM; Moore J; Falck JR; Hammock BD; Campbell WB; Nithipatikom K
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2838-44. PubMed ID: 18441205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha.
    Zhao HX; Wang XL; Wang YH; Wu Y; Li XY; Lv XP; Zhao ZQ; Zhao RR; Liu HR
    Basic Res Cardiol; 2010 Jan; 105(1):109-18. PubMed ID: 19597757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
    Xie L; Pi X; Wang Z; He J; Willis MS; Patterson C
    J Mol Cell Cardiol; 2015 Mar; 80():156-65. PubMed ID: 25633836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roxadustat Markedly Reduces Myocardial Ischemia Reperfusion Injury in Mice.
    Deguchi H; Ikeda M; Ide T; Tadokoro T; Ikeda S; Okabe K; Ishikita A; Saku K; Matsushima S; Tsutsui H
    Circ J; 2020 May; 84(6):1028-1033. PubMed ID: 32213720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
    Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
    Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore.
    Ong SG; Lee WH; Theodorou L; Kodo K; Lim SY; Shukla DH; Briston T; Kiriakidis S; Ashcroft M; Davidson SM; Maxwell PH; Yellon DM; Hausenloy DJ
    Cardiovasc Res; 2014 Oct; 104(1):24-36. PubMed ID: 25063991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.
    Adluri RS; Thirunavukkarasu M; Dunna NR; Zhan L; Oriowo B; Takeda K; Sanchez JA; Otani H; Maulik G; Fong GH; Maulik N
    Antioxid Redox Signal; 2011 Oct; 15(7):1789-97. PubMed ID: 21083501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.
    Alánová P; Husková Z; Kopkan L; Sporková A; Jíchová Š; Neckář J; Imig JD; Klevstig M; Kolář F; Rami Reddy N; Falck JR; Sadowski J; Nishiyama A; Kramer HJ; Melenovský V; Červenková L; Kujal P; Vernerová Z; Červenka L
    Vascul Pharmacol; 2015 Oct; 73():45-56. PubMed ID: 26304700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.
    Kalakech H; Tamareille S; Pons S; Godin-Ribuot D; Carmeliet P; Furber A; Martin V; Berdeaux A; Ghaleh B; Prunier F
    J Mol Cell Cardiol; 2013 Dec; 65():98-104. PubMed ID: 24140799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
    Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal surgical incision induces remote preconditioning of trauma (RPCT) via activation of bradykinin receptors (BK2R) and the cytochrome P450 epoxygenase pathway in canine hearts.
    Gross GJ; Baker JE; Moore J; Falck JR; Nithipatikom K
    Cardiovasc Drugs Ther; 2011 Dec; 25(6):517-22. PubMed ID: 21786213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury.
    Hyvärinen J; Hassinen IE; Sormunen R; Mäki JM; Kivirikko KI; Koivunen P; Myllyharju J
    J Biol Chem; 2010 Apr; 285(18):13646-57. PubMed ID: 20185832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats.
    Mao X; Wang T; Liu Y; Irwin MG; Ou JS; Liao XL; Gao X; Xu Y; Ng KF; Vanhoutte PM; Xia Z
    PLoS One; 2013; 8(7):e68949. PubMed ID: 23874823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protectin D1 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating PI3K/AKT Signaling Pathway.
    Zhang P; Wang J; Wang X; Wang L; Xu S; Gong P
    J Cardiovasc Transl Res; 2024 Apr; 17(2):376-387. PubMed ID: 37580643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic-Ischemic Injury in the Neonatal Rat.
    Chu HX; Jones NM
    Neurochem Res; 2016 Mar; 41(3):515-22. PubMed ID: 26108712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.